Clinical Trials Directory

Trials / Completed

CompletedNCT01482507

Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Optimus Clinical Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diffusion Weighted Imaging (DWI) MRI will assist in differentiating poor prognosis bone oedema more effectively than traditional T2 weighted MRI in patients with early Rheumatoid Arthritis (RA).

Detailed description

Assess DWI MRI in patients with early Rheumatoid Arthritis to determine whether the MRI method will assist in differentiating poor prognosis bone oedema more effectively than traditional T2 weighted MRI. Aim 1: To compare DWI MRI with T2 weighted MRI for the discrimination of different types of bone oedema lesions in patients with early RA. Aim 2: To examine the association between the presence of different types of bone oedema lesions detected on DWI MRI and T2 weighted MRI and the development of subsequent joint bone erosion as detected on i) MRI and ii) standard plain radiographs.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-11-30
Last updated
2018-04-06

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01482507. Inclusion in this directory is not an endorsement.